Novel therapies targeting NF-κB signal for triple-negative breast cancer patients with poor prognosis caused by loss of CYLD expression

Hitomi Arakaki

Presentation information

International Session (Oral)

International Session (Oral)1

Sat. Nov 2, 2024 3:45 PM - 4:45 PM 第8会場 (幕張メッセ国際会議場 3F 304会議室)

座長: Masashi Nagata（Department of Pharmacy, Institute of Science Tokyo Hospital), Takanori Taogoshi（Hiroshima University Hospital）

[IO-03] Novel therapies targeting NF-κB signal for triple-negative breast cancer patients with poor prognosis caused by loss of CYLD expression

^○Hitomi Arakaki¹, Akari Kuwano¹, Chika Hirai¹, Chica Saigo², Ayumi Kanemaru¹, Mitsuhiro Hayashi³, Hideyuki Saito^1,2, Yuki Narita^1,2, Hirofumi Jono^1,2 (1.Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 2.Department of Pharmacy, Kumamoto University Hospital, 3.Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.